 
The Patent Office Journal 31/08/2012 
13569
(12) PATENT APPLICATION PUBLICATION (21) Application No.436/MUMNP/2012 A 
(19) INDIA  
(22) Date of filing of Application :21/02/2012 (43) Publication Date : 31/08/2012 
  
(54) Title of the invention : GALECTIN-3 AND CARDIAC RESYNCHRONIZATION THERAPY  
  
(51) International classification  :G01N 33/68  
(31) Priority Document No  :61/236,712  
(32) Priority Date  :25/08/2009 
(33) Name of priority country  :U.S.A. 
(86) International Application No 
        Filing Date 
:PCT/US2010/046689
:25/08/2010 
(87) International Publication No  :WO/2011/031493  
(61) Patent of Addition to Application 
Number  
        Filing Date 
:NA 
:NA 
(62) Divisional to Application Number 
        Filing Date 
:NA 
:NA  
  
(71)Name of Applicant :  
   1)BG MEDICINE, INC. 
      Address of Applicant :610 LINCOLN STREET, WALTHAM, 
MA 02451 UNITED STATES OF AMERICA. 
(72)Name of Inventor : 
   1)MUNTENDAM, PIETER  
(57) Abstract : 
The present invention relates to materials and methods for monitoring and predicting a heart failure patients physiological response to 
cardiac resynchronization therapy. More specifically, the present invention relates to the endogenous protein galectin-3 and its use in 
monitoring progression of disease in a patient undergoing cardiac resynchronization therapy, and as a predictor of response to cardiac 
resynchronization therapy. 
  
  
No. of Pages : 26 No. of Claims : 27 
